Why Does ES-SCLC Remain So Deadly?
Extensive-stage small-cell lung cancer (ES-SCLC) is an aggressive form of lung cancer, accounting for ~70% of…
Articles
How to Manage Anaplastic Lymphoma Kinase (ALK) Cancer: Targeted Therapies and Strategies for Better Outcomes
Introduction Anaplastic Lymphoma Kinase (ALK) is a genetic mutation that can drive the development of…
Is Diffuse Large B-cell Lymphoma Still an Unsolved Puzzle in Precision Oncology?
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), accounting…
Is Colorectal Cancer Curable? From Symptoms to Survival
Introduction “It was just some blood in my stool. I thought it was hemorrhoids. But…
Is Atopic Dermatitis a Skin Condition or a Systemic Warning?
🔍 What is Atopic Dermatitis? Atopic dermatitis (AD) is a chronic inflammatory skin condition affecting…
Why Does Chronic Lymphocytic Leukemia Remain a Silent Threat?
🔍What is Chronic Lymphocytic Leukemia? Chronic Lymphocytic Leukemia (CLL) is a slow-growing blood cancer characterized…
How to Catch Ovarian Cancer Early: Signs, Risks & 5 Proactive Steps
Ovarian cancer is often called a “silent killer” because its early symptoms are vague and…
Hemophilia A: Is a Cure Possible?
🧬 What is the Hemophilia Type A? Hemophilia A, or classic hemophilia, is a rare…
Can We Outsmart Multiple Myeloma’s Genetic Maze?
Multiple myeloma (MM) is a type of blood cancer that affects plasma cells, a crucial…
Sogroya® (Somapacitan): The First Once-Weekly Long-Acting Growth Hormone Therapy
Novo Nordisk announced that its innovative growth hormone analogue Sogroya® (somapacitan) has been approved by…